Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
David is a senior breast oncologist with a number of research and governance interests.
He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.
Recent publications
-
Corrigendum to "Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study" [Eur J Cancer 222 (2025) 115472].
Journal article
Steventon L. et al, (2025), Eur J Cancer, 223
-
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in England.
Journal article
Steventon L. et al, (2025), Eur J Cancer, 222
-
SMALL: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer-protocol for a phase III randomised multicentre trial.
Journal article
Elder K. et al, (2025), BMJ Open, 15
-
The impact of the COVID-19 pandemic on the use of systemic therapy for patients diagnosed with cancer in England: A population-based study with a focus on breast and lung cancer.
Journal article
Webster L. et al, (2025), Cancer Epidemiol, 96
-
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.
Journal article
Kazmi F. et al, (2025), Cochrane Database Syst Rev, 3